Andrew M. Bellizzi

7.9k total citations · 1 hit paper
161 papers, 3.9k citations indexed

About

Andrew M. Bellizzi is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Andrew M. Bellizzi has authored 161 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 63 papers in Epidemiology and 55 papers in Surgery. Recurrent topics in Andrew M. Bellizzi's work include Neuroendocrine Tumor Research Advances (54 papers), Lung Cancer Research Studies (34 papers) and Pancreatic and Hepatic Oncology Research (31 papers). Andrew M. Bellizzi is often cited by papers focused on Neuroendocrine Tumor Research Advances (54 papers), Lung Cancer Research Studies (34 papers) and Pancreatic and Hepatic Oncology Research (31 papers). Andrew M. Bellizzi collaborates with scholars based in United States, Canada and Italy. Andrew M. Bellizzi's co-authors include Edward B. Stelow, James R. Howe, Thomas M. O’Dorisio, Jessica E. Maxwell, Wendy L. Frankel, Jason L. Hornick, Scott K. Sherman, Joseph S. Dillon, Stacey E. Mills and Kendall J. Keck and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of Clinical Investigation.

In The Last Decade

Andrew M. Bellizzi

152 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics

2021 188 citations Nicholas Borcherding, Ajaykumar Vishwakarma et al. Communications Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew M. Bellizzi United States	34	2.2k	1.5k	1.0k	857	712	161	3.9k
Antonino Maiorana Italy	33	2.0k 0.9×	805 0.5×	702 0.7×	315 0.4×	675 0.9×	197	3.9k
Michael A. den Bakker Netherlands	35	1.1k 0.5×	755 0.5×	500 0.5×	595 0.7×	676 0.9×	109	3.2k
Junji Shibahara Japan	37	1.3k 0.6×	730 0.5×	1.2k 1.2×	438 0.5×	1.3k 1.8×	152	4.7k
Birgitte Federspiel Denmark	28	2.3k 1.1×	2.5k 1.7×	477 0.5×	1.6k 1.9×	354 0.5×	76	3.6k
Gheeyoung Choe South Korea	41	1.4k 0.6×	827 0.6×	1.2k 1.2×	595 0.7×	1.3k 1.8×	210	5.5k
Özgür Mete Canada	45	1.7k 0.8×	2.2k 1.4×	3.1k 2.9×	1.0k 1.2×	799 1.1×	218	7.4k
Yoshiki Mikami Japan	41	921 0.4×	1.2k 0.8×	1.5k 1.4×	214 0.2×	737 1.0×	231	5.3k
Annette Ramaswamy Germany	35	1.8k 0.8×	586 0.4×	999 1.0×	249 0.3×	1.2k 1.7×	110	3.7k
G. Klöppel Germany	24	2.4k 1.1×	2.2k 1.5×	1.0k 1.0×	1.2k 1.4×	750 1.1×	56	4.2k
Silvia Uccella Italy	27	1.7k 0.8×	1.7k 1.1×	501 0.5×	994 1.2×	364 0.5×	122	2.9k

Countries citing papers authored by Andrew M. Bellizzi

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Bellizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Bellizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Bellizzi more than expected).

Fields of papers citing papers by Andrew M. Bellizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Bellizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Bellizzi. The network helps show where Andrew M. Bellizzi may publish in the future.

Co-authorship network of co-authors of Andrew M. Bellizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Bellizzi. A scholar is included among the top collaborators of Andrew M. Bellizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Bellizzi. Andrew M. Bellizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Jeremy, et al.. (2025). Risk Factors and Prognosis of Peritoneal Metastases in Small Bowel Neuroendocrine Tumor Patients. Annals of Surgical Oncology. 33(1). 265–274.

Neyaz, Azfar, et al.. (2025). Optimal Approaches to Grading Enteropancreatic Neuroendocrine Tumors Using Ki-67 Proliferation Index: Hotspot and Whole-Slide Digital Quantitative Analysis. Modern Pathology. 38(8). 100780–100780. 2 indexed citations

Tran, Catherine G., Guiying Li, James E. Egan, et al.. (2024). Abstract 3578: A systematic NEN spheroid drug screen reveals a novel drug resistance mechanism in small bowel NETs. Cancer Research. 84(6_Supplement). 3578–3578. 1 indexed citations

Li, Hui, et al.. (2023). Altered MANF Expression in Pancreatic Acinar and Ductal Cells in Chronic Alcoholic Pancreatitis: A Cross-Sectional Study. Biomedicines. 11(2). 434–434. 3 indexed citations

Sherman, Scott K., Patrick Breheny, Po Hien Ear, et al.. (2023). Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors. Endocrine Abstracts.

Greipp, Patricia T., Darlene L. Knutson, Sara M. Kloft‐Nelson, et al.. (2021). BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation. Archives of Pathology & Laboratory Medicine. 146(7). 840–845. 6 indexed citations

Scott, Aaron T., Terry A. Braun, Bartley Brown, et al.. (2021). Presacral neuroendocrine tumors associated with the Currarino syndrome. American Journal of Medical Genetics Part A. 185(5). 1582–1588. 3 indexed citations

Samuelson, Megan I., et al.. (2021). Rapid Validation of Whole-Slide Imaging for Primary Histopathology Diagnosis. American Journal of Clinical Pathology. 155(5). 638–648. 13 indexed citations

Rowan, Daniel J., Kiran K. Mangalaparthi, Roger K. Moreira, et al.. (2021). Metallothionein immunohistochemistry has high sensitivity and specificity for detection of Wilson disease. Modern Pathology. 35(7). 946–955. 13 indexed citations

10.

Borcherding, Nicholas, Ajaykumar Vishwakarma, Andrew P. Voigt, et al.. (2021). Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Communications Biology. 4(1). 122–122. 188 indexed citations breakdown →

11.

Scott, Aaron T., Patrick Breheny, Po Hien Ear, et al.. (2020). Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clinical Cancer Research. 26(8). 2011–2021. 40 indexed citations

12.

Scott, Aaron T., Patrick Breheny, Kendall J. Keck, et al.. (2018). Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. 165(1). 166–175. 64 indexed citations

13.

Strosberg, Jonathan, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.. (2017). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 46(6). 707–714. 262 indexed citations

14.

O’Leary, Brianne R., Melissa A. Fath, Andrew M. Bellizzi, et al.. (2015). Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 21(7). 1741–1751. 57 indexed citations

15.

Maxwell, Jessica E., Scott K. Sherman, Guiying Li, et al.. (2015). Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors. Cancer Genetics. 208(11). 564–570. 19 indexed citations

16.

Gailey, Michael P., Andrew M. Bellizzi, & Chris S. Jensen. (2015). Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens. Applied immunohistochemistry & molecular morphology. 24(1). 11–15. 6 indexed citations

17.

Hagen, Jussara, Sara M. Reed, Agshin F. Taghiyev, et al.. (2014). RABL6A Promotes G1–S Phase Progression and Pancreatic Neuroendocrine Tumor Cell Proliferation in an Rb1-Dependent Manner. Cancer Research. 74(22). 6661–6670. 28 indexed citations

18.

Bellizzi, Andrew M.. (2013). Assigning Site of Origin in Metastatic Neuroendocrine Neoplasms. Advances in Anatomic Pathology. 20(5). 285–314. 86 indexed citations

19.

Bellizzi, Andrew M., et al.. (2009). Basaloid Squamous Cell Carcinoma of the Esophagus: Assessment for High-risk Human Papillomavirus and Related Molecular Markers. The American Journal of Surgical Pathology. 33(11). 1608–1614. 38 indexed citations

20.

Burlina, Alberto, Antonella Peduto, A. Di Palma, et al.. (2006). An unusual clinical and biochemical presentation of ornithine transcarbamylase deficiency in a male patient. Journal of Inherited Metabolic Disease. 29(1). 179–181. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact